Your browser doesn't support javascript.
loading
The mutational landscape in chronic myelomonocytic leukemia and its impact on allogeneic hematopoietic cell transplantation outcomes: a Center for Blood and Marrow Transplantation Research (CIBMTR) analysis.
Mei, Matthew; Pillai, Raju; Kim, Soyoung; Estrada-Merly, Noel; Afkhami, Michelle; Yang, Lixin; Meng, Zhuo; Abid, Muhammad Bilal; Aljurf, Mahmoud; Bacher, Ulrike; Beitinjaneh, Amer; Bredeson, Christopher; Cahn, Jean-Yves; Cerny, Jan; Copelan, Edward; Cutler, Corey; DeFilipp, Zachariah; Diaz Perez, Miguel Angel; Farhadfar, Nosha; Freytes, César O; Gadalla, Shahinaz M; Ganguly, Siddhartha; Gale, Robert Peter; Gergis, Usama; Grunwald, Michael R; Hamilton, Betty K; Hashmi, Shahrukh; Hildebrandt, Gerhard C; Lazarus, Hillard M; Litzow, Mark; Munker, Reinhold; Murthy, Hemant S; Nathan, Sunita; Nishihori, Taiga; Patel, Sagar S; Rizzieri, David; Seo, Sachiko; Shah, Mithun Vinod; Solh, Melhem; Verdonck, Leo F; Vij, Ravi; Sobecks, Ronald M; Oran, Betul; Scott, Bart L; Saber, Wael; Nakamura, Ryotaro.
Afiliación
  • Mei M; Department of Hematology/HCT, City of Hope National Medical Center, Duarte. mamei@coh.org.
  • Pillai R; Department of Pathology, City of Hope, Duarte.
  • Kim S; Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI; CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee.
  • Estrada-Merly N; CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, .
  • Afkhami M; Department of Pathology, City of Hope, Duarte.
  • Yang L; Department of Pathology, City of Hope, Duarte.
  • Meng Z; Beckman Research Institute, City of Hope, Duarte.
  • Abid MB; Divisions of Hematology/Oncology and Infectious Diseases, Department of Medicine, Medical College of Wisconsin, Milwaukee.
  • Aljurf M; Department of Oncology, King Faisal Specialist Hospital Center and Research, Riyadh.
  • Bacher U; Department of Hematology, Inselspital, Bern University Hospital, University of Bern.
  • Beitinjaneh A; Division of Transplantation and Cellular Therapy, University of Miami Hospital and Clinics, Sylvester Comprehensive Cancer Center, Miami.
  • Bredeson C; The Ottawa Hospital Transplant and Cellular Therapy Program, Ottawa, ON.
  • Cahn JY; Department of Hematology, CHU Grenoble Alpes, Université Grenoble Alpes, Grenoble.
  • Cerny J; Division of Hematology/Oncology, Department of Medicine, University of Massachusetts Medical Center, Worcester.
  • Copelan E; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte.
  • Cutler C; Stem Cell Transplantation and Cellular Therapy, Dana-Farber Cancer Institute, Boston.
  • DeFilipp Z; Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Boston.
  • Diaz Perez MA; Department of Hematology/Oncology, Hospital Infantil Universitario Niño Jesús, Madrid.
  • Farhadfar N; Division of Hematology/Oncology, University of Florida College of Medicine, Gainesville.
  • Freytes CO; University of Texas Health Science Center at San Antonio, San Antonio.
  • Gadalla SM; Divsion of Cancer Epidemiology and Genetics, NIH-NCI Clinical Genetics Branch, Rockville.
  • Ganguly S; Division of Hematological Malignancy and Cellular Therapeutics, University of Kansas Health System, Kansas City.
  • Gale RP; Haematology Research Centre, Department of Immunology and Inflammation, Imperial College London, London.
  • Gergis U; Department of Medical Oncology, Division of Hematological Malignancies, Thomas Jefferson University, Philadelphia.
  • Grunwald MR; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte.
  • Hamilton BK; Blood and Marrow Transplant Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland.
  • Hashmi S; Department of Internal Medicine, Mayo Clinic, Rochester, MN; Department of Medicine, Sheikh Shakhbout Medical City, Abu Dhabi.
  • Hildebrandt GC; Markey Cancer Center, University of Kentucky, Lexington.
  • Lazarus HM; University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland.
  • Litzow M; Division of Hematology and Transplant Center, Mayo Clinic Rochester, Rochester.
  • Munker R; Markey Cancer Center, University of Kentucky, Lexington.
  • Murthy HS; Division of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville.
  • Nathan S; Section of Bone Marrow Transplant and Cell Therapy, Rush University Medical Center, Chicago.
  • Nishihori T; Department of Blood and Marrow Transplant and Cellular Immunotherapy (BMT CI), Moffitt Cancer Center, Tampa.
  • Patel SS; Blood and Marrow Transplant Program, Huntsman Cancer Institute, University of Utah, Salt Lake City.
  • Rizzieri D; Novant Health Cancer Institute; Charlotte.
  • Seo S; Department of Hematology and Oncology, Dokkyo Medical University, Tochigi.
  • Shah MV; Mayo Clinic, Rochester.
  • Solh M; The Blood and Marrow Transplant Group of Georgia, Northside Hospital, Atlanta.
  • Verdonck LF; Department of Hematology/Oncology, Isala Clinic, Zwolle.
  • Vij R; Division of Medical Oncology, Washington University School of Medicine, St. Louis.
  • Sobecks RM; Cleveland Clinic, Cleveland.
  • Oran B; Department of Stem Cell Transplantation, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston.
  • Scott BL; Fred Hutchinson Cancer Research Center, Seattle.
  • Saber W; CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee.
  • Nakamura R; Department of Hematology/HCT, City of Hope National Medical Center, Duarte.
Haematologica ; 108(1): 150-160, 2023 01 01.
Article en En | MEDLINE | ID: mdl-35443559
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Leucemia Mielomonocítica Crónica / Trasplante de Células Madre Hematopoyéticas Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Humans / Middle aged Idioma: En Revista: Haematologica Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Leucemia Mielomonocítica Crónica / Trasplante de Células Madre Hematopoyéticas Tipo de estudio: Prognostic_studies Límite: Adult / Aged / Humans / Middle aged Idioma: En Revista: Haematologica Año: 2023 Tipo del documento: Article